Cleared Special

MOLLI 2 System

K253888 · Stryker Endoscopy · General & Plastic Surgery
Dec 2025
Decision
27d
Days
Class 2
Risk

About This 510(k) Submission

K253888 is an FDA 510(k) clearance for the MOLLI 2 System, a Marker, Radiographic, Implantable (Class II — Special Controls, product code NEU), submitted by Stryker Endoscopy (San Jose, US). The FDA issued a Cleared decision on December 31, 2025, 27 days after receiving the submission on December 4, 2025. This device falls under the General & Plastic Surgery review panel. Regulated under 21 CFR 878.4300.

Submission Details

510(k) Number K253888 FDA.gov
FDA Decision Cleared SESE
Date Received December 04, 2025
Decision Date December 31, 2025
Days to Decision 27 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code NEU — Marker, Radiographic, Implantable
Device Class Class II — Special Controls
CFR Regulation 21 CFR 878.4300

Similar Devices — NEU Marker, Radiographic, Implantable

All 109
HydroMARK? Plus Breast Biopsy Site Marker (Dragonfly Shape); HydroMARK? Plus Breast Biopsy Site Marker (Hummingbird Shape)
K253761 · Devicor Medical Products, Inc. · Jan 2026
SCOUT MD Surgical Guidance System
K252892 · Merit Medical Systems, Inc. · Dec 2025
VizMark Preloaded Tissue Marker Device (VM-0001)
K251989 · Breast-Med, Inc. · Dec 2025
MammoSTAR Biopsy Site Identifier
K251748 · Carbon Medical Technologies, Inc. · Jul 2025
UltraCor? Twirl? Breast Tissue Marker
K243642 · Bard Peripheral Vascular, Inc. · Mar 2025
SmartClip Secure Soft Tissue Marker
K233639 · Elucent Medical, Inc. · Dec 2024